Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-04, Stock:PFE, The news for the past five days is as follows:
2020-10-28: NEWS1: Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's -Times.NEWS2: Amgen’s Earnings and Sales Climb, Driven by Its Biosimilars.NEWS3: Why Pfizer Stock Dropped Today.NEWS4: ‘We could see daily averages well over 1,000 deaths per day’ going into winter: doctor.NEWS5: Coronavirus Latest: Wednesday, October 28.NEWS6: Coronavirus update: Case surges spark fear in markets globally; experts wary about a vaccine by the end of the year.NEWS7: Company News for Oct 28, 2020.NEWS8: EU must step up response to COVID-19, Commission warns as infections spike.NEWS9: Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks.NEWS10: Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?.NEWS11: AstraZeneca and J&J Resume Late-Stage Trials: How It Shakes Up the Coronavirus Vaccine Race.NEWS12: Exelixis' (EXEL) Applications for Cabometyx-Opdivo Combo Accepted (Revised).NEWS13: PRESS DIGEST- New York Times business news - Oct 28.NEWS14: Pfizer (PFE) Q3 2020 Earnings Call Transcript.
2020-10-29: NEWS1: Moderna Third-Quarter Earnings Show Soaring Revenue, R&D Costs.NEWS2: Coronavirus Latest: Thursday, October 29.NEWS3: Top Research Reports for UnitedHealth, Adobe & Pfizer.NEWS4: Fauci says first U.S. COVID-19 vaccines could ship late December or early January.NEWS5: NYC Positive Rate Spikes; Midwest Surge at Record: Virus Update.NEWS6: Why BioNTech Stock Is Jumping Today.NEWS7: Moderna Stock Jumps as Biotech Rakes in Revenue for Covid Vaccine.NEWS8: Amgen (AMGN) Losing Altitude Despite Strong Quarter.NEWS9: UK Government Expects Verdict On Pfizer's Vaccine Before Christmas: Report.NEWS10: Got $1,000? These 2 Top Stocks Are Great Buys Right Now.NEWS11: Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids.NEWS12: Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids.NEWS13: Pfizer or Merck: Which Pharma Stock Has More Upside Potential?.NEWS14: Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - Times.NEWS15: PRESS DIGEST-British Business - Oct.29.
2020-10-30: NEWS1: Overconfident Predictions for Stocks, the Election, and a Covid-19 Vaccine.NEWS2: Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit.NEWS3: U.K. regulator is accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report.NEWS4: Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn.NEWS5: How Novavax Has a 2-Pronged Approach to Vaccine Sales.NEWS6: Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study.NEWS7: Novavax lays out specific minority targets for U.S. COVID-19 vaccine trial.NEWS8: U.S. approves combination of Pfizer's Upjohn and Mylan.NEWS9: The Zacks Analyst Blog Highlights: UnitedHealth Group, Adobe, Pfizer, Intel and T-Mobile US.NEWS10: UK starts accelerated reviews for COVID-19 vaccines from AstraZeneca and Pfizer - Bloomberg.NEWS11: What's the Outlook for BioNTech Stock?.NEWS12: What's the Outlook for BioNTech Stock?.
2020-11-02: NEWS1: Pfizer To Bypass US Government System For COVID Vaccine Distribution.NEWS2: A Pfizer Analyst's 3 Possible Coronavirus Vaccine Readout Scenarios.NEWS3: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, Pfizer, Novartis, AstraZeneca and J&J.NEWS4: CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial.NEWS5: Mylan (MYL) to Report Q3 Earnings: Is a Beat in the Cards?.NEWS6: 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020.NEWS7: Early Covid-19 Vaccine Hopes Have a Math Problem.NEWS8: Here’s What a Covid-19 Vaccine Could Be Worth to Pfizer Stock.NEWS9: It Might Not Be A Great Idea To Buy Pfizer Inc. (NYSE:PFE) For Its Next Dividend.NEWS10: A Covid-19 Vaccine Faces a Major Hurdle.
2020-11-03: NEWS1: Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx).NEWS2: Cherry Picking Is Tempting.NEWS3: Bristol Myers Says Its Psoriasis Drug Outperformed Amgen’s Otezla.NEWS4: Analyst Report: Pfizer Inc..NEWS5: Market Update: BSX, TPR, FLEX, K, PFE, YUM, CBOE, PYPL, ANET.

Answer: Rise